Delphic look at the future standard of care in cancers
Oncology Futures is a new product from Whistler Associates, Inc. that utilizes a Delphi Process research technique with a group of cancer site specific experts.  This technique is used to predict alternative futures for the care of each type of cancer and how treatment in each disease will evolve over the coming five year period.  Rather than just describing all the new drugs and therapies that are in development, Oncology Futures uses the Delphi Process to predict which of those drugs in development will actually make it to market and how they will impact the standard of care in each disease.  Oncology Futures also provides alternative futures based on specific events that could occur in the coming five years.  Oncology Futures is an ideal tool to help marketers, clinical development specialists, forecasters and market researchers better understand what the future may look like in their disease of interest.  To learn more go to: